BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Haupt S, Caramia F, Herschtal A, Soussi T, Lozano G, Chen H, Liang H, Speed TP, Haupt Y. Identification of cancer sex-disparity in the functional integrity of p53 and its X chromosome network. Nat Commun 2019;10:5385. [PMID: 31772231 DOI: 10.1038/s41467-019-13266-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Shea LK, Akhave NS, Sutton LA, Compton LA, York C, Ramakrishnan SM, Miller CA, Wartman LD, Chen DY. Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice. J Invest Dermatol 2023;143:232-241.e6. [PMID: 36055401 DOI: 10.1016/j.jid.2022.08.037] [Reference Citation Analysis]
2 Kirtane K, St John M, Fuentes-Bayne H, Patel SP, Mardiros A, Xu H, Ng EW, Go WY, Wong DJ, Sunwoo JB, Welch JS. Genomic Immune Evasion: Diagnostic and Therapeutic Opportunities in Head and Neck Squamous Cell Carcinomas. J Clin Med 2022;11. [PMID: 36555876 DOI: 10.3390/jcm11247259] [Reference Citation Analysis]
3 Vågerö D, Cederström A, van den Berg GJ. Food abundance in men before puberty predicts a range of cancers in grandsons. Nat Commun 2022;13:7507. [PMID: 36473854 DOI: 10.1038/s41467-022-35217-1] [Reference Citation Analysis]
4 He F, Furones AR, Landegren N, Fuxe J, Sarhan D. Sex dimorphism in the tumor microenvironment - From bench to bedside and back. Semin Cancer Biol 2022;86:166-79. [PMID: 35278635 DOI: 10.1016/j.semcancer.2022.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fujihara KM, Zhang BZ, Jackson TD, Ogunkola MO, Nijagal B, Milne JV, Sallman DA, Ang C, Nikolic I, Kearney CJ, Hogg SJ, Cabalag CS, Sutton VR, Watt S, Fujihara AT, Trapani JA, Simpson KJ, Stojanovski D, Leimkühler S, Haupt S, Phillips WA, Clemons NJ. Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restriction. Sci Adv 2022;8:eabm9427. [DOI: 10.1126/sciadv.abm9427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guo M, Xiong Y. Revisiting the effects of Cas9 on p53-inactivating mutations reveals sex-biased genome editing by CRISPR-Cas9.. [DOI: 10.1101/2022.08.03.502574] [Reference Citation Analysis]
7 Guo M, Fang Z, Chen B, Songyang Z, Xiong Y. Identifying new regulators of evolutionarily conserved differential chromosome X dosage compensation.. [DOI: 10.1101/2022.07.25.501478] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yang H, Wang XK, Wang JB, Zhao FH, Fan JH, Qiao YL, Taylor PR, Abnet CC. Combined risk factors and risk of upper gastrointestinal cancer mortality in the Linxian general population. Int J Cancer 2022. [PMID: 35689438 DOI: 10.1002/ijc.34160] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Abe S, Kawai K, Nozawa H, Sasaki K, Murono K, Emoto S, Ozawa T, Yokoyama Y, Nagai Y, Anzai H, Sonoda H, Yamauchi S, Sugihara K, Ishihara S. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study. BMC Cancer 2022;22:486. [PMID: 35501727 DOI: 10.1186/s12885-022-09615-z] [Reference Citation Analysis]
10 Cine N, Ali Sen E, Demir G, Gokbayrak M, Guzdolu E, Sertdemir N, Aydin D, Kurtas O, Reka S, Sunnetci-akkoyunlu D, Eren-keskin S, Uygun K, Cabuk D, Gorkem Aksu M, Zafer Canturk N, Savli H. The diagnostic importance of pathogenic variants and variant coexistence determined by NGS-based liquid biopsy approach in patients with lung adenocarcinoma. Molecular and Cellular Probes 2022. [DOI: 10.1016/j.mcp.2022.101819] [Reference Citation Analysis]
11 Cardano M, Buscemi G, Zannini L. Sex disparities in DNA damage response pathways: Novel determinants in cancer formation and therapy. iScience 2022;25:103875. [DOI: 10.1016/j.isci.2022.103875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kim SY. Oxidative Stress and Gender Disparity in Cancer. Free Radic Res 2022;:1-39. [PMID: 35118928 DOI: 10.1080/10715762.2022.2038789] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Rubin JB. The spectrum of sex differences in cancer. Trends in Cancer 2022. [DOI: 10.1016/j.trecan.2022.01.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
14 Chen JS, Clarke R, Haddad AF, Wang EJ, Lacroix M, Sarkar IN, Zand R, Chen ES, Toms SA. The effect of levetiracetam treatment on survival in patients with glioblastoma: a systematic review and meta-analysis. J Neurooncol 2022. [PMID: 34982371 DOI: 10.1007/s11060-021-03940-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Shi X, Young S, Morahan G. Identification of Genetic Variants Associated with Sex-Specific Lung-Cancer Risk. Cancers (Basel) 2021;13:6379. [PMID: 34945000 DOI: 10.3390/cancers13246379] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Rockwell NC, Yang W, Warrington NM, Staller MV, Griffith M, Griffith OL, Gurnett CA, Cohen BA, Baldridge D, Rubin JB. Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis. Cancer Research Communications 2021;1:148-163. [DOI: 10.1158/2767-9764.crc-21-0026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Alhebshi H, Tian K, Patnaik L, Taylor R, Bezecny P, Hall C, Muller PAJ, Safari N, Creamer DPM, Demonacos C, Mutti L, Bittar MN, Krstic-Demonacos M. Evaluation of the Role of p53 Tumour Suppressor Posttranslational Modifications and TTC5 Cofactor in Lung Cancer. Int J Mol Sci 2021;22:13198. [PMID: 34947995 DOI: 10.3390/ijms222413198] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Pinto JA, Araujo JM, Gómez HL. Sex, immunity, and cancer. Biochim Biophys Acta Rev Cancer 2021;1877:188647. [PMID: 34767966 DOI: 10.1016/j.bbcan.2021.188647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Zhang C, He Z, Cheng L, Cao J. Investigation of Prognostic Markers of Lung Adenocarcinoma Based on Tumor Metabolism-Related Genes. Front Genet 2021;12:760506. [PMID: 34737767 DOI: 10.3389/fgene.2021.760506] [Reference Citation Analysis]
20 Broestl L, Rubin JB. Sexual Differentiation Specifies Cellular Responses to DNA Damage. Endocrinology 2021;162:bqab192. [PMID: 34478502 DOI: 10.1210/endocr/bqab192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Mancini F, Giorgini L, Teveroni E, Pontecorvi A, Moretti F. Role of Sex in the Therapeutic Targeting of p53 Circuitry. Front Oncol 2021;11:698946. [PMID: 34307167 DOI: 10.3389/fonc.2021.698946] [Reference Citation Analysis]
22 Rockwell N, Yang W, Warrington N, Griffith M, Griffith O, Gurnett C, Cohen B, Baldridge D, Rubin J. p53 mutations exhibit sex specific gain-of-function activity in gliomagenesis.. [DOI: 10.1101/2021.06.11.448124] [Reference Citation Analysis]
23 Liu B, Zhou M, Li X, Zhang X, Wang Q, Liu L, Yang M, Yang D, Guo Y, Zhang Q, Zheng H, Wang Q, Li L, Chu X, Wang W, Li H, Song F, Pan Y, Zhang W, Chen K. Interrogation of gender disparity uncovers androgen receptor as the transcriptional activator for oncogenic miR-125b in gastric cancer. Cell Death Dis 2021;12:441. [PMID: 33947843 DOI: 10.1038/s41419-021-03727-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
24 Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Sex disparities matter in cancer development and therapy. Nat Rev Cancer 2021;21:393-407. [PMID: 33879867 DOI: 10.1038/s41568-021-00348-y] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
25 Kfoury N, Qi Z, Prager BC, Wilkinson MN, Broestl L, Berrett KC, Moudgil A, Sankararaman S, Chen X, Gertz J, Rich JN, Mitra RD, Rubin JB. Brd4-bound enhancers drive cell-intrinsic sex differences in glioblastoma. Proc Natl Acad Sci U S A 2021;118:e2017148118. [PMID: 33850013 DOI: 10.1073/pnas.2017148118] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
26 Haupt S, Haupt Y. Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity. Front Genet 2021;12:632719. [PMID: 33664771 DOI: 10.3389/fgene.2021.632719] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Lopes-Ramos CM, Quackenbush J, DeMeo DL. Genome-Wide Sex and Gender Differences in Cancer. Front Oncol 2020;10:597788. [PMID: 33330090 DOI: 10.3389/fonc.2020.597788] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
28 Tricarico R, Nicolas E, Hall MJ, Golemis EA. X- and Y-Linked Chromatin-Modifying Genes as Regulators of Sex-Specific Cancer Incidence and Prognosis. Clin Cancer Res 2020;26:5567-78. [PMID: 32732223 DOI: 10.1158/1078-0432.CCR-20-1741] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
29 Credendino SC, Neumayer C, Cantone I. Genetics and Epigenetics of Sex Bias: Insights from Human Cancer and Autoimmunity. Trends Genet 2020;36:650-63. [PMID: 32736810 DOI: 10.1016/j.tig.2020.06.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
30 Freudenstein D, Litchfield C, Caramia F, Wright G, Solomon BJ, Ball D, Keam SP, Neeson P, Haupt Y, Haupt S. TP53 Status, Patient Sex, and the Immune Response as Determinants of Lung Cancer Patient Survival. Cancers (Basel) 2020;12:E1535. [PMID: 32545367 DOI: 10.3390/cancers12061535] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
31 Rubin JB, Lagas JS, Broestl L, Sponagel J, Rockwell N, Rhee G, Rosen SF, Chen S, Klein RS, Imoukhuede P, Luo J. Sex differences in cancer mechanisms. Biol Sex Differ 2020;11:17. [PMID: 32295632 DOI: 10.1186/s13293-020-00291-x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 98] [Article Influence: 30.0] [Reference Citation Analysis]
32 Kfoury N, Qi Z, Prager BC, Wilkinson MN, Broestl L, Berrett KC, Moudgil A, Sankararaman S, Chen X, Gertz J, Rich JN, Mitra RD, Rubin JB. Brd4-bound enhancers drive cell intrinsic sex differences in glioblastoma.. [DOI: 10.1101/199059] [Reference Citation Analysis]